Analysts have anticipation on stock's earnings per share of $-0.14. The stock has a market capitalization of $86.20, a P/E ratio of -0.53 and a beta of 1.31. Total debt to equity ratio of the company for most recent quarter is N/A whereas long term debt to equity ratio for most recent quarter is N/A. Genocea Biosciences, Inc. (NASDAQ:GNCA) to a Buy rating from a Hold rating in a report posted on Tuesday, February 6th, 2018.
Trading volume, or volume, is the number of shares or contracts that point towards the full activity of a security or stock market for a given period. Analysts consider this stock active, since it switched over with 4,618,511 shares as compared to its average volume of 5.12M shares. Higher volume for a stock is an indicator of higher liquidity in the market. Cantor Fitzgerald assumed coverage on Genocea Biosciences in a research note on Monday, March 5th. Analysts mean recommendation for the stock is 2.40. However, -40.16 percent is noted as its 180.00 days or half-yearly performance. This is represented as the equation (P/EPS), where P is the market price and EPS is the earnings per share. The stock rating was maintained by Needham with "Hold" on Friday, November 3. These ratios are other measures of operational efficiency and performance. Profitability merely is the capacity to make a profit, and a gain is what is left over from income earned after you have deducted all costs and expenses related to obtaining the income. Values can range from 0 to -100. Both the shorter and longer timeframes are used by the traders for shorter and longer purposes.
Shifting gears to the Relative Strength Index, the 14-day RSI is now sitting at 43.57, the 7-day is 41.41, and the 3-day is now at 35.45 for Geologix Expl Inc (GIXEF). Moving averages are the basis of many technical trend-following systems. Historical statistical volatility is a measure of how much the stock price fluctuated during a given time period. The stock "GNCA" was trading at a distance of -8.68% from 20 days simple moving average, and its distance from 50 days simple moving average is -15.21% while it has a distance of -60.34% from the 200 days simple moving average.
VOLATILITY FACTOR: The stock remained 6.47% volatile in recent week and indicated 6.95% volatility in last month.
Teradyne, Inc. a US based Company, belongs to Technology sector and Semiconductor Equipment & Materials industry.
Equities analysts expect Genocea Biosciences Inc (NASDAQ:GNCA) to announce ($0.14) earnings per share for the current fiscal quarter, according to Zacks Investment Research. The firm is having a distance of -5.1% form 20 day moving average, SMA 50 of -8.1% and an SMA 200 of 1.61%. The company has market cap of $73.14 million. Return on assets ratio of the Company was -157.80%. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an predictable return higher than the risk-free rate of interest. This company shares are 313.79% off its target price of $3.6 and the current market capitalization stands at $75.85M. The Institutional ownership of the firm is 61.50% while Insiders ownership is 1.50%. As Teradyne, Inc. has a P/S, P/E and P/B values of 4.01, 18.82 and 4.16 respectively. Its P/Cash valued at 4.82. Instead, the 52 Week Range is generally used more as a descriptive metric to describe what the stock has done and not what it will do.
Earnings growth expectations are completely unreliable. The formula for calculating the price-earnings ratio for any stock is simple: the market value per share divided by the earnings per share (EPS).
The impact of earnings growth is exponential.
The company showed -1.98 diluted EPS growth for trailing twelve months. The stock observed Sales growth of -2.40% during past 5 years. The true range indicator is the greatest of the following: current high less the current low, the absolute value of the current high less the previous close and the absolute value of the current low less the previous close.